
Pangaea Data is a healthcare technology company leveraging AI to improve patient outcomes by identifying untreated and under-treated patients across various diseases. Their flagship product, the PALLUX platform, uses AI configured on clinical guidelines to analyze patient records with high accuracy, enabling healthcare providers and pharmaceutical companies to find more suitable patients for screening and treatment without disrupting existing workflows. The platform addresses care gaps in prevalent and rare hard-to-diagnose conditions such as COPD, CKD, cancer cachexia, lung and ovarian cancer, Crohn's disease, and lupus nephritis. Pangaea Data collaborates with global partners including Alexion and Topcon Healthcare, and operates with offices in South San Francisco, London, and Hong Kong. Their business model is primarily SaaS, focusing on healthcare providers and pharmaceutical companies as customers, aiming to reduce healthcare burden and improve clinical care at scale.

Pangaea Data is a healthcare technology company leveraging AI to improve patient outcomes by identifying untreated and under-treated patients across various diseases. Their flagship product, the PALLUX platform, uses AI configured on clinical guidelines to analyze patient records with high accuracy, enabling healthcare providers and pharmaceutical companies to find more suitable patients for screening and treatment without disrupting existing workflows. The platform addresses care gaps in prevalent and rare hard-to-diagnose conditions such as COPD, CKD, cancer cachexia, lung and ovarian cancer, Crohn's disease, and lupus nephritis. Pangaea Data collaborates with global partners including Alexion and Topcon Healthcare, and operates with offices in South San Francisco, London, and Hong Kong. Their business model is primarily SaaS, focusing on healthcare providers and pharmaceutical companies as customers, aiming to reduce healthcare burden and improve clinical care at scale.
Headquarters: South San Francisco (offices in London and Hong Kong)
Core product: PALLUX — clinical-grade AI platform to identify untreated/under-treated patients
Customers / market: Healthcare providers and pharmaceutical companies (SaaS model)
Founders: Dr. Vibhor Gupta and Prof. Yi-Ke (Yike) Guo
Recent funding: Corporate Round closed May 27, 2025; strategic investment from Topcon Healthcare
Identifying and closing care gaps in diagnosis, coding, and treatment across a wide range of clinical conditions using AI applied to clinical records.
2017
Biotechnology Research
Strategic investment from Topcon Healthcare announced in conjunction with this round.
Follow-on participation from Hambro Perks, Ascension and private investors.
“Backed by strategic and institutional investors including IQ Capital, Ascension, Topcon Healthcare, Hambro Perks and a mix of angel/private investors”
| Company |
|---|
As the Quality Assurance & Regulatory Affairs Manager, you will be responsible for building and leading the company’s regulatory and quality foundation from the ground up. In this role, you will be expected to develop and implement a scalable QMS, prepare relevant projects for global regulatory submissions, and drive a culture of quality across the organization.
Key Responsibilities
Develop and Implement Regulatory & Quality Strategy:
Training & Process Implementation:
Cross-Functional Collaboration:
RequirementsPersonal Traits
Must Haves:
Nice to Have:
Perks And Benefits